Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
Coronary Heart Disease
Interventions
DEVICE

Angiolite stent

Following index PCI, patients will be followed via scheduled clinic and/or phone contact at 1-, 3-, 6-, 12- and 24-month. Patient will be randomized to undergo a scheduled repeat coronary angiogram and OCT evaluation at either at 3- or 6-month post index PCI.

Trial Locations (4)

Unknown

Hospital Vall D'Hebron, Barcelona

Hospital Universitario de Leon, León

Hospital Clinico San Carlos, Madrid

Hospital Universitario Marqués de Valdecilla, Santander

All Listed Sponsors
collaborator

iVascular

UNKNOWN

lead

Josep Rodes-Cabau

OTHER

NCT02776267 - Percutaneous Coronary Intervention With the Angiolite Drug-eluting Stent: an Optical Cohenrece Tomography Study | Biotech Hunter | Biotech Hunter